Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab
Crossref DOI link: https://doi.org/10.1007/s13312-020-1901-z
Published Online: 2020-05-10
Published Print: 2020-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Balasubramanian, S.
Nagendran, T. M.
Ramachandran, B.
Ramanan, A. V.
Text and Data Mining valid from 2020-05-10
Version of Record valid from 2020-05-10
Article History
First Online: 10 May 2020
Ethics
: <i>Competing interest</i>: None stated.
Free to read: This content has been made available to all.